Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis

Ghada Alsaleh(Nuffield Orthopaedic Centre), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Mathieu Ehlinger(Hôpitaux Universitaires de Strasbourg), Dominique Wachsmann(Inserm), L. Sparsa(Hôpitaux Universitaires de Strasbourg), Emmanuel Chatelus(Laboratoire National de Référence), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique)
Arthritis Research & Therapy
July 8, 2010
10.1186/ar3073
Cited by 75

Related Papers

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
|Blood|1997|346
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207